首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   39723篇
  免费   13100篇
  国内免费   1篇
电工技术   730篇
化学工业   17111篇
金属工艺   332篇
机械仪表   701篇
建筑科学   1692篇
能源动力   853篇
轻工业   7229篇
水利工程   292篇
石油天然气   45篇
无线电   6952篇
一般工业技术   11556篇
冶金工业   890篇
原子能技术   4篇
自动化技术   4437篇
  2022年   15篇
  2021年   281篇
  2020年   2091篇
  2019年   3161篇
  2018年   3090篇
  2017年   3416篇
  2016年   3876篇
  2015年   3944篇
  2014年   3861篇
  2013年   4985篇
  2012年   2673篇
  2011年   2315篇
  2010年   2608篇
  2009年   2493篇
  2008年   2033篇
  2007年   1882篇
  2006年   1658篇
  2005年   1381篇
  2004年   1338篇
  2003年   1316篇
  2002年   1259篇
  2001年   1094篇
  2000年   1076篇
  1999年   453篇
  1998年   81篇
  1997年   66篇
  1996年   48篇
  1995年   29篇
  1994年   32篇
  1993年   22篇
  1992年   16篇
  1991年   17篇
  1990年   20篇
  1989年   13篇
  1988年   12篇
  1987年   15篇
  1986年   12篇
  1985年   10篇
  1984年   12篇
  1983年   8篇
  1982年   19篇
  1981年   19篇
  1980年   10篇
  1979年   7篇
  1978年   5篇
  1977年   11篇
  1976年   11篇
  1974年   4篇
  1972年   4篇
  1970年   4篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
Iodoperfluooralkylation of terminal alkenes and alkynes is effectively photo‐promoted by benzophenone 2 (BP) or the photoreducible copper(II) complex 1 . In particular, BP at 1 mol% in methanol upon 365 nm irradiation with a low‐pressure mercury lamp (type TLC=thin layer chromatography, 6 W) results in a fast reaction with excellent reaction yields. Complex 1 and BP 2 exhibited very similar reactivity, suggesting that the reactions involving 1 are likely to be governed by the benzophenone photoactivation processes, rather than copper(I)/(II) redox processes. Mechanistic investigations using transient absorption spectroscopy revealed that a deactivation pathway of the benzophenone triplet (3BP*) is via its reaction with the methanol solvent. We propose that the generated radicals, in particular .CH2OH, play a key role in the initiation step forming Rf. by reacting with RfI, Rf. then entering a radical chain cycle. 1H NMR studies provided evidence that a substantial amount (∼7% NMR yield) of the hemiacetal CH3OCH2OH is formed, i.e., the possible by‐product of the reaction between .CH2OH and RfI. Finally, DFT calculations indicate that a triplet‐triplet energy transfer (TTET) process from 3BP* to perfluorooctyl iodide (C8F17I) is unlikely or should be rather slow under the reaction conditions, consistent with the transient absorption studies.

  相似文献   

32.
The copper‐catalyzed reaction of 5‐substituted penta‐1,4‐diyn‐3‐yl acetates with P(O)H compounds to efficiently give a new class of phosphonyl diynes is reported. The reaction may take place through a regioselective nucleophilic attack of phosphorus nucleophiles on Cu‐allenylidene intermediates to form allenyl intermediates followed by a rapid allene‐alkyne isomerization process. The synthetic utility of the obtained products is demonstrated.

  相似文献   

33.
34.
In parts of Africa and Asia, self‐medication with a hot water infusion of Artemisia annua (Artemisia tea) is a common practice for a number of ailments including malaria and cancer. In our earlier work, such an extract showed better potency than artemisinin alone against both chloroquine‐sensitive and ‐resistant parasites. In this study, in vitro tests of the infusion in MCF7 cells showed high IC50 values (>200 μM ). The combination of artemisinin and 3‐caffeoylquinic acid (3CA), two major components in the extract, was strongly antagonistic and gave a near total loss of cytotoxicity for artemisinin. We observed that the interaction of 3CAs with another cytotoxic compound, cisplatin, showed potentiation of activity by 2.5‐fold. The chelation of cellular iron by 3CA is hypothesized as a possible explanation for the loss of artemisinin activity.  相似文献   
35.
36.
37.
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that arises due to a complex and variable interplay between elements including age, genetic, and environmental risk factors that manifest as the loss of dopaminergic neurons. Contemporary treatments for PD do not prevent or reverse the extent of neurodegeneration that is characteristic of this disorder and accordingly, there is a strong need to develop new approaches which address the underlying disease process and provide benefit to patients with this debilitating disorder. Mitochondrial dysfunction, oxidative damage, and inflammation have been implicated as pathophysiological mechanisms underlying the selective loss of dopaminergic neurons seen in PD. However, results of studies aiming to inhibit these pathways have shown variable success, and outcomes from large-scale clinical trials are not available or report varying success for the interventions studied. Overall, the available data suggest that further development and testing of novel therapies are required to identify new potential therapies for combating PD. Herein, this review reports on the most recent development of antioxidant and anti-inflammatory approaches that have shown positive benefit in cell and animal models of disease with a focus on supplementation with natural product therapies and selected synthetic drugs.  相似文献   
38.
The development of cost‐effective and flexible electrodes is demanding in the field of energy storage. Herein, flexible FexOy/nitrogen‐doped carbon films (FexOy/NC‐MOG) are prepared by facile electrospinning of Fe‐based metal–organic gels (MOGs) followed by high‐temperature carbonization. This approach allows the even mixing of fragile coordination polymers with polyacrylonitrile into flexible films while reserving the structural characteristics of coordination polymers. After thermal treatment, FexOy/NC‐MOG films possess uniformly distributed FexOy nanoparticles and larger accessible surface areas than traditional FexOy‐NC films without MOG. Taking advantage of the unique structure, FexOy/NC‐MOG exhibits a superior rate performance (449.8 mA h g?1 at 5000 mA g–1) and long cycle life (629.3 mA h g–1 after 500 cycles at 1000 mA g–1) when used as additive‐free anodes in lithium‐ion batteries.  相似文献   
39.
40.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号